Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Other Cancers in Long-Term Survivors of Chronic Lymphocytic Leukemia: Incidence and Prognostic Relevance

Lorenzo Falchi, MD, Michael Keating, MBBS, Susan Lerner, MS, Xuemei Wang, PhD, Kplola Y Elhor Gbito, MD MPH, Sara S. Strom, PhD, William G. Wierda, MD PhD, Alessandra Ferrajoli, MD

Blood (2014) 124 (21): 3323.

https://doi.org/10.1182/blood.V124.21.3323.3323

Published: 2014

Journal Articles

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Katarina Sevcikova, MD, Zuo Zhuang, MD PhD, Guillermo Garcia-Manero, MD, Ricardo Alvarez, MD, Hagop M. Kantarjian, MD, Mego Michal, MD, Constance Albarracin, MD PhD, Guilin Tang, MD, Sara S. Strom, PhD, James M. Reuben, PhD, Joseph D Khoury, MD

Blood (2014) 124 (21): 962.

https://doi.org/10.1182/blood.V124.21.962.962

Published: 2014

Journal Articles

Chronic Myeloid Leukemia in Chronic Phase: Survival in the Era of Tyrosine Kinase Inhibitors Is Similar to That of the General Population in All Age Groups

Koji Sasaki, Sara S. Strom, PhD, Susan O'Brien, MD, Elias Jabbour, MD, Farhad Ravandi, MD, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Sherry R. Pierce, RN, BS, Hagop M. Kantarjian, MD, Jorge E. Cortes

Blood (2014) 124 (21): 1801.

https://doi.org/10.1182/blood.V124.21.1801.1801

Published: 2014

Journal Articles

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Kristin A Rand, PhD, M.P.H., Chi Song, M.S., Amie E. Hwang, PhD, M.P.H., Carol A. Huff, MD, Leon Bernal-Mizrachi, MD, Michael H Tomasson, MD, Sikander Ailawadhi, MD, David J. Van Den Berg, PhD, Xin Sheng, PhD, John J. Graff, PhD, M.S., David V. Conti, PhD, Todd Zimmerman, MD, Edward Peters, D.MD S.M, Sc.D., Seema Singhal, MD, Cathryn H. Bock, PhD, Karen Pawlish, M.P.H., Graham A Colditz, MD, Dr.PH., Xin Sheng, PhD, Alexander Stram, M.S., Sara S. Strom, PhD, Benjamin Rybicki, PhD, Rick Kittles, PhD, Howard Terebelo, DO, Janet Stanford, PhD, MPH, Phyllis J. Goodman, PhD, Sonja I Berndt, PhD, John Carpten, PhD, Anselm JM Hennis, MSc,PhD MRCP, FRCP, Lisa Chu, PhD, M.P.H., Graham Casey, PhD, W R Driver, MSPH, Eric A. Klein, MD, M. Christina Leske, MD MPH, Esther John, PhD, Adam Bryant Murphy, MD, Christine Neslund-Dudas, PhD, Victoria L. Stevens, PhD, Curtis Pettaway, MD, Wei Zheng, MD PhD MPH, Suh-Yuh Wu, M.A., John Witte, PhD, Siqun Lilly Zheng, MD, Jianfeng Xu, MD,Dr.PH, Nikhil C. Munshi, MD, Ann Hsing, PhD, Sue Ingles, PhD, Jayesh Mehta, MD, Lisa B. Signorello, PhD, Stephen Jacob Chanock, MD, Barbara Nemesure, PhD, Ann M Mohrbacher, MD, Nalini Janakiraman, MD, William J Blot, MD, Brian E. Henderson, MD, Laurence N. Kolonel, MD PhD, Kenneth C. Anderson, MD, Brian C-H Chiu, PhD, Jeffrey Zonder, MD, Robert Z. Orlowski, PhD MD, Sagar Lonial, MD, Daniel O. Stram, PhD, Christopher Haiman, Sc.D., Wendy Cozen, DO, MPH

Blood (2014) 124 (21): 2030.

https://doi.org/10.1182/blood.V124.21.2030.2030

Published: 2014

Journal Articles

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

Scott J. Hebbring, Susan L. Slager, Narendranath Epperla, Joseph J. Mazza, Zhan Ye, Zhiyi Zhou, Sara J. Achenbach, Daniel A. Vasco, Timothy G. Call, Kari G. Rabe, Neil E. Kay, Neil E. Caporaso, Mark C. Lanasa, Nicola J. Camp, Sara S. Strom, Lynn R. Goldin, James R. Cerhan, Murray H. Brilliant, Steven J. Schrodi

Blood (2013) 121 (1): 237–238.

https://doi.org/10.1182/blood-2012-08-450221

Published: 2013

Journal Articles

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Lorenzo Falchi, MD, Michael J. Keating, MD, Susan Lerner, MS, Xuemei Wang, MS, Sara S. Strom, PhD, William G. Wierda, MD, Alessandra Ferrajoli, M.D.

Blood (2012) 120 (21): 3896.

https://doi.org/10.1182/blood.V120.21.3896.3896

Published: 2012

Journal Articles

Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans

Catherine C. Coombs, Laura Z. Rassenti, Lorenzo Falchi, Susan L. Slager, Sara S. Strom, Alessandra Ferrajoli, J. Brice Weinberg, Thomas J. Kipps, Mark C. Lanasa

Blood (2012) 120 (8): 1687–1690.

https://doi.org/10.1182/blood-2012-02-408799

Published: 2012

Includes: Supplemental data

Journal Articles

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Blood (2012) 120 (4): 843–846.

https://doi.org/10.1182/blood-2012-03-413591

Published: 2012

Includes: Supplemental data

Journal Articles

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

Dushyant Verma, Hagop Kantarjian, Sara S. Strom, Mary Beth Rios, Elias Jabbour, Alfonso Quintas-Cardama, Srdan Verstovsek, Farhad Ravandi, Susan O'Brien, Jorge Cortes

Blood (2011) 118 (16): 4353–4358.

https://doi.org/10.1182/blood-2011-06-362889

Published: 2011

Journal Articles

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Blood (2011) 117 (6): 1911–1916.

https://doi.org/10.1182/blood-2010-09-308205

Published: 2011

Includes: Supplemental data

Journal Articles

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Blood (2009) 114 (22): 1232.

https://doi.org/10.1182/blood.V114.22.1232.1232

Published: 2009

Journal Articles

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Mark C Lanasa, MD, PhD, Sallie D Allgood, MS, Susan L Slager, PhD, Nicola J Camp, PhD, Neil E. Kay, MD, Logan G Spector, PhD, Laura Z. Rassenti, PhD, Curtis A. Hanson, MD, Jon P Gockerman, MD, Barbara K Goodman, PhD, Sara S Strom, PhD, Timothy G Call, MD, James R Cerhan, MD, PhD, Jose Leis, MD, Gerald Marti, MD, PhD, Lynn Goldin, PhD, J. Brice Weinberg, Neil E Caporaso, MD

Blood (2009) 114 (22): 1241.

https://doi.org/10.1182/blood.V114.22.1241.1241

Published: 2009

Journal Articles

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

Dana E. Rollison, Nadia Howlader, Martyn T. Smith, Sara S. Strom, William D. Merritt, Lynn A. Ries, Brenda K. Edwards, Alan F. List

Blood (2008) 112 (1): 45–52.

https://doi.org/10.1182/blood-2008-01-134858

Published: 2008

Journal Articles

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Gabrielle S. Sellick, Lynn R. Goldin, Ruth W. Wild, Susan L. Slager, Laura Ressenti, Sara S. Strom, Martin J. S. Dyer, Francesca R. Mauro, Gerald E. Marti, Stephen Fuller, Matthew Lyttelton, Thomas J. Kipps, Michael J. Keating, Timothy G. Call, Daniel Catovsky, Neil Caporaso, Richard S. Houlston

Blood (2007) 110 (9): 3326–3333.

https://doi.org/10.1182/blood-2007-05-091561

Published: 2007

Journal Articles

First Report of National Estimates of the Incidence of Myelodysplastic Syndromes and Chronic Myeloproliferative Disorders from the U.S. SEER Program.

Dana E. Rollison, PhD, Matthew Hayat, PhD, Martyn Smith, PhD, Sara S. Strom, PhD, William D. Merritt, PhD, Lynn Ries, MS, Brenda K. Edwards, PhD, Alan F. List, MD

Blood (2006) 108 (11): 247.

https://doi.org/10.1182/blood.V108.11.247.247

Published: 2006

Journal Articles

Risk Factors of Myelodysplastic Syndromes (MDS): A Case-Control Study.

Sara S. Strom, PhD, Yun Gu, MS, Stephen K. Gruschkus, MPH, Elihu H. Estey, MD

Blood (2004) 104 (11): 71.

https://doi.org/10.1182/blood.V104.11.71.71

Published: 2004

Journal Articles

Second Cancers after CLL Diagnosis.

Yun Gu, MS, Sara S. Strom, PhD, Susan Lerner, MS, Michael J. Keating, MD

Blood (2004) 104 (11): 18.

https://doi.org/10.1182/blood.V104.11.18.18

Published: 2004

Journal Articles

Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work

Marcos de Lima, Sara S. Strom, Michael Keating, Hagop Kantarjian, Sherry Pierce, Susan O'Brien, Emil Freireich, Elihu Estey

Blood (1997) 90 (12): 4719–4724.

https://doi.org/10.1182/blood.V90.12.4719

Published: 1997

NARROW

Other Cancers in Long-Term Survivors of Chronic Lymphocytic Leukemia: Incidence and Prognostic Relevance

Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases

Chronic Myeloid Leukemia in Chronic Phase: Survival in the Era of Tyrosine Kinase Inhibitors Is Similar to That of the General Population in All Age Groups

Genetic Susceptibility Markers of Multiple Myeloma in African-Americans

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia

Other Cancers in Patients with Chronic Lymphocytic Leukemia Requiring Therapy: Association with Prognostic Factors and Impact On Survival

Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans

Common variation at 6p21.31 ( BAK1 ) influences the risk of chronic lymphocytic leukemia

Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Monoclonal B-Cell Lymphocytosis Is Commonly Observed Among Unaffected Members of High Risk CLL Families.

Family-Associated Monoclonal B Lymphocytosis Shows Differences From CLL That Suggest An Indolent Biology.

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

First Report of National Estimates of the Incidence of Myelodysplastic Syndromes and Chronic Myeloproliferative Disorders from the U.S. SEER Program.

Risk Factors of Myelodysplastic Syndromes (MDS): A Case-Control Study.

Second Cancers after CLL Diagnosis.

Implications of Potential Cure in Acute Myelogenous Leukemia: Development of Subsequent Cancer and Return to Work

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only